Goldman Sachs Group Inc Pulmonx Corp Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 210,477 shares of LUNG stock, worth $338,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210,477
Previous 196,499
7.11%
Holding current value
$338,867
Previous $1.32 Million
58.77%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding LUNG
# of Institutions
118Shares Held
33.9MCall Options Held
0Put Options Held
0-
Primecap Management CO Pasadena, CA5.16MShares$8.32 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.56MShares$5.73 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$4.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$3.69 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$3.04 Million0.11% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $60M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...